HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pablo Pérez-Durán Selected Research

Leukemia

12/2019GATA3-Controlled Nucleosome Eviction Drives MYC Enhancer Activity in T-cell Development and Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pablo Pérez-Durán Research Topics

Disease

2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2020 - 12/2019
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2019
1Leukemia
12/2019

Drug/Important Bio-Agent (IBA)

1ChromatinIBA
12/2019
1Nucleosomes (Nucleosome)IBA
12/2019

Therapy/Procedure

1Combination Drug Therapy (Combination Chemotherapy)
11/2020
1Drug Therapy (Chemotherapy)
11/2020